OTC · Biotechnology

OptiBiotix Health Plc (OPBXF) Stock

$0.22 +0.00% OTC: OPBXF Healthcare

OptiBiotix Health Plc is a life sciences enterprise based in the United Kingdom, specializing in the research and development of innovative microbiome modulators. The company's core activity involves pinpointing and crafting unique microbial strains, compounds, and formulations.

Valuation

MetricValue
Price$0.22
Market Cap$20.06M
P/E Ratio-1.46
P/B Ratio0.90
P/S Ratio4.87
EPS (TTM)$0.03
52-Week High$0.22
52-Week Low$0.22
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-52.92%
ROA-56.44%
ROCE-48.13%
Gross Margin52.66%
Operating Margin-268.61%
Net Margin-333.62%
Debt/Equity0.00
Current Ratio4.27

Annual Financials (USD)

Metric20172018202020212022
Revenue$0$1.0M$2.0M$2.0M$0
Operating Profit$-2.0M$-1.0M$-1.0M$-1.0M$-2.0M
Net Profit$2.0M$-2.0M$6.0M$6.0M$3.0M
EPS$0.02$-0.02$0.06$0.07$0.03
Op Margin-1113.1%-291.4%-73.0%-61.7%-544.6%

Balance Sheet (USD)

Metric20172018202020212022
Total Assets$8.0M$8.0M$14.0M$20.0M$12.0M
Total Liabilities$1.0M$1.0M$2.0M$2.0M$1.0M
Cash$1.0M$1.0M$1.0M$2.0M$1.0M
Borrowings$0$0$1.0M$1.0M$0

Latest News

Where Will Solana Be in 3 Years? Motley Fool · Jul 23, 2026 Amazon’s highly rated long-lasting, portable fan with a cooling plate is just $18 TheStreet · Jul 23, 2026 Amazon Outlet slashes the price of furniture by up to 50%, with deals starting at $13 TheStreet · Jul 23, 2026 Equinor (EQNR) Q2 2026 Earnings Call Transcript Motley Fool · Jul 23, 2026 Santander (SAN) Q2 2026 Earnings Call Transcript Motley Fool · Jul 23, 2026

Cash Flow (USD)

Metric20172018202020212022
Operating Cash Flow$-2.0M$-1.0M$-1.0M$-2.0M$-1.0M
Investing Cash Flow$0$-1.0M$-1.0M$0$0
Financing Cash Flow$0$2.0M$2.0M$3.0M$0
Net Cash Flow$-2.0M$0$0$1.0M$-1.0M
Free Cash Flow$-2.0M$-2.0M$-1.0M$-2.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-1.62
FCF Yield-15.47%
Quick Ratio3.49
Interest Coverage0.00
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMHVAmerican Hemp Ventures, Inc. $0.98 +0.00% — $16.47M 0.00%
BFFTFBiofrontera AG $0.33 -95.24% -0.97 $19.35M 0.00%
EMMLFOKYO Pharma Limited $0.01 +0.00% -6.57 $22.73M 0.00%
GRAMFTPCO Holding Corp. $0.16 -15.36% -0.07 $20.12M 0.00%
KMSTFKadimastem Ltd $3.21 -3.02% -1.52 $9.50M 0.00%

About OptiBiotix Health Plc

OptiBiotix Health Plc is a life sciences enterprise based in the United Kingdom, specializing in the research and development of innovative microbiome modulators. The company's core activity involves pinpointing and crafting unique microbial strains, compounds, and formulations. These are then integrated into food ingredients, dietary supplements, and active agents, with the objective of positively influencing human physiological processes and delivering significant health advantages. Its comprehensive range of products targets key aspects of well-being. For effective and hunger-free weight management, OptiBiotix offers Slimbiome, a natural ingredient, and SlimBiome Medical, a natural supplement. CholBiome is a food supplement formulated to support healthy cholesterol levels. The probiotic Lactobacillus plantarum LPLDL contributes to cardiovascular health and overall vitality. LPGOS, a beneficial galactooligosaccharide, is incorporated into various food products and applications to lower cardiovascular risk factors and promote better health. WellBiome, a blend of functional fibers and minerals, bolsters general health and well-being by encouraging a diverse gut microbiome. Additionally, Sweetbiotix provides a sweetening solution for food and beverages. Fundamentally, OptiBiotix's solutions are engineered to prevent and manage prevalent chronic lifestyle diseases, including obesity, hypercholesterolemia, adverse lipid profiles, and diabetes. The company was established in 2012 and operates from its headquarters in York, United Kingdom.

OptiBiotix Health Plc is headquartered in GB.

OptiBiotix Health Plc (OPBXF) stock trades at $0.22 with a market capitalization of $20.06M. The stock is valued at a price-to-earnings (P/E) ratio of -1.46, price-to-book of 0.90, price-to-sales of 4.87. Over the past 52 weeks the stock has ranged between $0.22 and $0.22, and currently trades at its 52-week high.

On profitability, OptiBiotix Health Plc generates a return on equity (ROE) of -52.92%, return on capital employed of -48.13%, an operating margin of -268.61%, a net profit margin of -333.62%.

Official website: www.optibiotix.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides